TRPV4 and endometrial cancer: TRPV4-mediated calcium influx modulates endometrial cancer cell migration, both in vitro and in vivo, via the activation of the RhoA/ROCK1 pathway, which in turn orchestrates cytoskeletal remodelling [25].